Table 1 Characteristics of study population by sex and age

Age (months)

Mean (SD)

51 (39)

52 (42)

13 (6)

42 (11)

85 (17)

138 (14)

CD4 (cells/mm³) p*: 0.014; <0.0001

Mean (SD)

708 (623)

606(512)

801(607)

760 (541)

477(494)

268(385)

Missing

17

12

16

4

7

2

Baseline who stage p: 0.944; 0.537

I: N(%)

30 (9.5)

37(10.9)

30 (12.9)

19(10.1)

16 (9.1)

2 (3.5)

II : N(%)

84(26.7)

77(22.8)

54(23.3)

50(26.6)

40 (22.9)

17 (29.8)

III: N(%)

191(61)

217(64.2)

142 (61.2)

115(61.2)

114 (65.1)

37 (64.9)

IV : N(%)

9 (2.9)

7(2.1)

6(2.6)

4(2.1)

5 (2.9)

1(1.8)

Missing

4

4

4

1

3

0

Outcome p^b: 0.325; 0.003

^aCOT(N,%)

207 (65.2)

217 (63.5)

141(59.7)

130(68.8)

115(64.6)

38(66.7)

D(N,%)

28 (8.8)

38(11.1)

37(15,7)

12(6.3)

11(6.2)

6(10.5)

LTF(N,%)

53(16.6)

56(16.4)

43(18.2)

27(14.3)

32(18.0)

7(12.3)

STOP(N,%)

2(0.6)

6(1.8)

4(1.7)

1(0.5)

3(1.7)

0(0.0)

TO(N,%)

28(8.8)

25(7.3)

11(4.7)

19(10.1)

17(9.6)

6(10.5)

Follow up time (months) p: 0.484; 0.001

Mean(SD)

46(25)

44(25)

40(24)

49(24)

47(26)

45(25)

Baseline HB (g/dl) p: 0.463; 0.327

Mean(SD)

10.44(3.91)

10.19(3.86)

10.29(4.01)

10.75(4.88)

9.98(2.46)

9.90(2.89)

Missing

71

83

65

34

43

12

Year of art initiation p: 0.848; 0.033

2005 (N,%)

32(10.1)

36(10.5)

17(25)

26(38.2)

22(32.4)

3(4.4)

2006(N,%)

77(24.2)

82(24.0)

47(29.6)

52(32.7)

43(27)

17(10.7)

2007(N,%)

50(15.7)

45(13.2)

26(27.4)

27(28.4)

32(33.7)

10(10.5)

2008(N,%)

62(19.5)

80(23.4)

67(47.2)

33(23.2)

35(24.6)

7(4.9)

2009 (N,%)

40(12.6)

44(12.9)

38(45.2)

26(31)

13(15.5)

7(8.3)

2010(N,%)

28(9.1)

27(7.9)

24(43.6)

10(18.2)

14(25.5)

7(12.7)

2011 (N,%)

29(9.1)

28(8.2)

17(29.8)

15(26.3)

19(33.3)

6(10.5)